Friday, 30 September 2016

European multicenter network to evaluate pharmacokinetics,
safety and efficacy of Meropenem in neonatal sepsis and meningitis.

Latest News

13 March 2014

Trial Status

As of March 7th, 2014, the trial status is the following: 189 patients have been randomised in NM1…
Read more
3 February 2014

Trial Status

As of January 31st, 2014, the trial status is the following: 175 patients have been randomised in…
Read more
31 December 2013

Consortium Meeting in Brussels - 25th & 26th February 2014

The Annual Consortium Meeting of NeoMero Project will take place this year in Brussels, at the…
Read more

Welcome in NeoMero

NeoMero project aims at adapting an off-patent medicine to the specific need of paediatric populations: in specific to evaluate PK, safety and efficacy of meropenem in comparison to standard care in late-onset sepsis and describe PK and safety in bacterial meningitis in neonates and infants aged less than 3 months in order to be able to register it for use in this age group with a PUMA.

This project has been funded with support by the European Commission under the FP7 programme, and has officially ended on 30th June 2015.

Reserved Area

Reserved Access to the our services for our Partners.

This project has received funding from the European Union’s Seventh Framework Programme for research,
technological development and demonstration under grant agreement no: 242146 - Call: FP7-HEALTH-2009-4.2-1

Copyright © 2010-2015 NeoMero | All rights reserved. Read the disclaimer. | Privacy policy | Cookie policy

 Mail to: